facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2016
vol. 103
 
Share:
Share:
abstract:
Special paper

Diagnostic and therapeutic guidelines of dermatitis herpetiformis (Duhring’s disease) – consensus of Polish Dermatological Society

Agnieszka Żebrowska
,
Elżbieta Waszczykowska
,
Cezary Kowalewski
,
Katarzyna Woźniak
,
Małgorzata Olszewska
,
Waldemar Placek
,
Rafał Czajkowski
,
Jacek Szepietowski
,
Rafał Białynicki-Birula
,
Marian Dmochowski

Przegl Dermatol 2016, 103, 95–101
Online publish date: 2016/05/03
View full text Get citation
 
PlumX metrics:
Dermatitis herpetiformis (Duhring’s disease) is an autoimmune blistering dermatosis with a characteristic polymorphic, itchy rash. The autoimmune process against transglutaminases (TGs) is connected with asymptomatic or with mild symptoms of gluten-sensitive enteropathy (GSE). The diagnostic approach in DH should rely on clinical evaluation, direct immunofluorescence of perilesional skin and evaluation of serum IgA antibodies with ELISA with one substrate of four substrates from which to choose (tTG, eTG, npG, neo-tTG) using the ELISA method. In cases showing an equivocal clinical-laboratory picture such an approach should be broadened by performing histopathology of lesional skin and examining the HLA DQ2/DQ8 haplotype. Combined treatment with dapsone and a gluten-free diet in individualized combinations is generally the therapeutic method of choice in DH.
keywords:

dermatitis herpetiformis, Duhring’s disease, IgA, transglutaminase, dapsone, gluten-free diet



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.